Please Observe:
Under listed kits are validated with the talked about batch quantity solely. Duty for batch to batch consistency doesn’t lies with ICMR.
Minimal acceptance standards of sensitivity and specificity of Speedy Ag Check Kits:
Validated as a Level of Care Check (POCT) with out transport to a laboratory setupSensitivity: 50% and above; Specificity: 95% and above
Validated in a laboratory setup with samples collected in Viral Transport Medium (VTM)- Sensitivity: 70% and above; Specificity: 99% and above
Antigen primarily based speedy assessments that are US-FDA permitted can be utilized immediately after due advertising and marketing approval from DCGI.
In June 2020, JOYSBIO Biotechnology proudly launched a brand new COVID-19 Antigen Speedy Check Equipment (Colloidal Gold). The brand new coronavirus antigen take a look at equipment is a lateral move immunoassay for the qualitative detection of SARS-COV-2 antigen (nucleocapsid protein) in higher respiratory samples with nasal swabs or saliva in the course of the acute section of an infection. An uncut sheet format is out there.
Options
- 15-minute speedy detection
- Straightforward-to-operate coronavirus antigen take a look at
- Much less-invasive nasal (NS) swab pattern assortment
- CE-IVD marked
- Accessible in half/5/20 assessments/field.
Efficiency Traits
JOYSBIO’s coronavirus Ag take a look at equipment was independently evaluated at Centro Diagnostico Delta S.r.l. in Italy between October 2020 and January 2021. A complete of 107 constructive specimens had been examined with JOYSBIO’s COVID-19 Antigen Speedy Check Equipment. These specimens had been collected from sufferers who’re suspected of COVID-19 with nasal swabs. The coronavirus antigen take a look at equipment’s sensitivity and specificity are in contrast towards a CE-IVD marked RT-PCR take a look at equipment. This medical analysis is carried out underneath the idea that SARS-CoV is not spreading locally.
Based on the medical evaluation of 492 samples, the detection sensitivity is 98.13%, and the specificity is 99.22%.
- Constructive % Settlement (PPA) = 105/107 (98.13%) (95%CI: 93.4%~99.8%)
- Adverse % Settlement (NPA) = 382/385 (99.22%) (95%CI:97.7%~99.8%)
- Accuracy = (105+382)/492×100%=98.98%
- Kappa = 2×(105×382-3×2)/(108×385+107 ×384) = 0.97>0.5
The restrict of detection (LOD) of this product is 1.6 x 102 TCID50/mL, calculated via a gradient dilution methodology.
COVID-19 Antigen Check Process
- Twist off the cap of the buffer bottle, fastidiously dispense all buffer into the extraction tube。
- After accumulating higher respiratory pattern with nasal swab, insert the swab into the extraction tube, plunge the swab up and down within the fluid for no less than 10 seconds. Maintain the swab towards the underside of the tube, rotate three turns. DO NOT splash liquid out of the tube.
- Take away the swab whereas squeezing the perimeters of the tube to extract the liquid from the swab.
- Press the nozzle cap firmly onto the extraction tube. Combine completely by swirling or flicking the underside of the tube.
- Gently squeeze the tube’s inflexible physique, dispense two (2) drops of the buffer-specimen combination into the pattern nicely on the coronavirus antigen take a look at cassette.
- Learn the take a look at outcomes between 15 and 20 minutes. Don’t learn the outcomes after 20 minutes.

Key Factors
- This interim steerage is meant for healthcare suppliers who order antigen assessments, obtain antigen take a look at outcomes, or carry out point-of-care testing, in addition to for laboratory professionals who carry out antigen testing in a laboratory setting or on the level of care and report these outcomes.
- The aim of this interim technical steerage is to help efficient medical and public well being use of antigen assessments for various testing conditions.
- This steerage applies to all medical and shopper makes use of of antigen assessments and isn’t particular to any specific age group.

Summary
Background
The Coronavirus illness 2019 (COVID-19) pandemic continues to unfold internationally. Therefore, there’s an pressing want for speedy, easy, and correct assessments to diagnose extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) an infection. Efficiency traits of the speedy SARS-CoV-2 antigen detection take a look at needs to be evaluated and in contrast with the gold customary real-time reverse transcription-polymerase chain response (RT-PCR) take a look at for prognosis of COVID-19 instances.
Strategies
The speedy SARS-CoV-2 antigen detection take a look at, Customary Q COVID-19 Ag equipment (SD Biosensor®, Republic of Korea), was in contrast with the real-time RT-PCR take a look at, Allplex 2019-nCoV Assay (Seegene®, Korea) for detection of SARS-CoV-2 in respiratory specimens. 4 hundred fifty-four respiratory samples (primarily nasopharyngeal and throat swabs) had been obtained from COVID-19 suspected instances and speak to people, together with pre-operative sufferers at Siriraj Hospital, Bangkok, Thailand throughout March–Might 2020.
Outcomes
Of 454 respiratory samples, 60 (13.2%) had been constructive, and 394 (86.8%) had been detrimental for SARS-CoV-2 RNA by real-time RT-PCR assay. The length from onset to laboratory take a look at in COVID-19 suspected instances and speak to people ranged from Zero to 14 days with a median of three days. The speedy SARS-CoV-2 antigen detection take a look at’s sensitivity and specificity had been 98.33% (95% CI, 91.06–99.96%) and 98.73% (95% CI, 97.06–99.59%), respectively. One false detrimental take a look at consequence was from a pattern with a excessive real-time RT-PCR cycle threshold (Ct), whereas 5 false constructive take a look at outcomes had been from specimens of pre-operative sufferers.
Human Streptococcus Pneumoniae (SP) Antigen Rapid Test Kit |
|||
abx092096-20tests | Abbexa | 20 tests | EUR 477.6 |
Avian Influenza Virus Antigen Rapid Test Kit (Colloidal gold) |
|||
abx092015-40tests | Abbexa | 40 tests | EUR 518.4 |
Newcastle Disease Virus Antigen Rapid Test Kit (Colloidal gold) |
|||
abx092016-40tests | Abbexa | 40 tests | EUR 518.4 |
Human Chlamydia Trachomatis Antigen Rapid Test Kit (Colloidal gold) |
|||
abx092049-20tests | Abbexa | 20 tests | EUR 276 |
Avian Influenza H5 Virus Antigen Rapid Test Kit (Colloidal gold) |
|||
abx092014-40tests | Abbexa | 40 tests | EUR 585.6 |
Avian Influenza H7 Virus Antigen Rapid Test Kit (Colloidal gold) |
|||
abx092017-40tests | Abbexa | 40 tests | EUR 518.4 |
SARS-CoV-2 Rapid Antigen Test Nasal |
|||
9901-NCOV-03G | Roche Diagnostics | 25 Tests/Kit | EUR 112.8 |
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke |
Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) |
|||
IOV87952 | INVBIO | 20T/kit | EUR 46.8 |
Description: Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in human saliva, using the rapid immunochromatographic method. The identification is based on the monoclonal antibodies specific for the novel coronvirus antigen. It will provide information for clinical doctors to prescribe correct medications. |
Accu-Tell COVID-19 IgG/IgM Rapid Test |
|||
GEN-B352-20tests | Accu test | 20 tests | EUR 283.2 |
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus. |
Accu-Tell COVID-19 IgG/IgM Rapid Test |
|||
GEN-B352-40tests | Accu test | 40 tests | EUR 385.2 |
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus. |
TruStrip RDT Anthrax Protective antigen 83 (PA83) Rapid Test cards, 25/pk |
|||
800-100-RDT-25 | Alpha Diagnostics | 1 pk | EUR 489.6 |
Melamine Rapid Test Kit |
|||
abx092011-50tests | Abbexa | 50 tests | EUR 444 |
Brucella Antibody Rapid Test Kit |
|||
abx092069-40tests | Abbexa | 40 tests | EUR 427.2 |
2019-nCoV IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) |
|||
GEN-402-25tests | All test | 25 tests | EUR 292.8 |
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus. |
Melamine (MEL) Rapid Test Kit |
|||
abx092057-50tests | Abbexa | 50 tests | EUR 444 |
Quinolones (QNs) Rapid Test Kit |
|||
abx092065-40tests | Abbexa | 40 tests | EUR 477.6 |
Salbutamol (SAL) Rapid Test Kit |
|||
abx092060-50tests | Abbexa | 50 tests | EUR 292.8 |
Quinolones (QNs) Rapid Test Kit |
|||
abx092067-40tests | Abbexa | 40 tests | EUR 477.6 |
Clenbuterol (CLE) Rapid Test Kit |
|||
abx092058-50tests | Abbexa | 50 tests | EUR 292.8 |
Ractopamine (RAC) Rapid Test Kit |
|||
abx092059-50tests | Abbexa | 50 tests | EUR 292.8 |
Tetracycline (TCs) Rapid Test Kit |
|||
abx092063-50tests | Abbexa | 50 tests | EUR 477.6 |
Sulfonamides (Sas) Rapid Test Kit |
|||
abx092064-40tests | Abbexa | 40 tests | EUR 477.6 |
NOVATest IgG/IgM Antibody Rapid Test Kit (NOVA Test) |
|||
UNCOV-40 | Atlas Link Technology | 40 Tests | EUR 115 |
Cow Brucella Antibody Rapid Test Kit |
|||
abx092071-40tests | Abbexa | 40 tests | EUR 427.2 |
Ciprofloxacin (CPFX) Rapid Test Kit |
|||
abx092066-50tests | Abbexa | 50 tests | EUR 477.6 |
Goat Brucella Antibody Rapid Test Kit |
|||
abx092070-40tests | Abbexa | 40 tests | EUR 427.2 |
Pig Parvovirus Antibody Rapid Test Kit |
|||
abx092074-50tests | Abbexa | 50 tests | EUR 385.2 |